EN DE
STOCK COMPARISON

MEDIPOST Co. vs Biotoxtech Co.: Fair Value & Quality

Both stocks run through our valuation models. Here is how MEDIPOST Co. (078160) and Biotoxtech Co. (086040) compare, as of Sep 24, 2026.

As of Sep 24, 2026, Fair Value Calculator sees Biotoxtech Co. as the less overvalued of the two: MEDIPOST Co. trades at KRW 8,970 versus a fair value of KRW 3,576 (-60%), while Biotoxtech Co. trades at KRW 2,240 versus KRW 1,916 (-14%).
MEDIPOST Co.
078160.KQ · KRW · Health Care
-60%
upside to fair value
overvalued
PriceKRW 8,970
Fair ValueKRW 3,576
Quality26/100
Biotoxtech Co.
086040.KQ · KRW · Health Care
-14%
upside to fair value
overvalued
PriceKRW 2,240
Fair ValueKRW 1,916
Quality61/100
Get comparisons like this free by email every month: the most undervalued quality stocks.

Head-to-head numbers

Green is the better side of a row, red the weaker one (for valuation multiples: lower = cheaper). Grey rows are for reference only and are not scored.

betterweakerfor reference, not scored

MEDIPOST Co.Biotoxtech Co.
Valuation
−60.1%Fair value upside−14.5%
Profitability
-26%Operating margin7%
-3%Return on assets2%
Growth
23%Revenue growth (YoY)9%
4.7%Avg. growth/yr (3Y)8.0%
8.7%Avg. growth/yr (5Y)12.2%
n/aValue creation/yr−25.7%
Balance & size
0.03×Debt / equity0.28×
$245MMarket cap$24M
expensiveGrowth qualitymixed

Biotoxtech Co. leads: 1 to 6 metric wins.

n/a = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

MEDIPOST Co.of which business quality 26 · market factors 19 Biotoxtech Co.of which business quality 56 · market factors 27
ProfitabilityMargins and returns on capital today
4
19
Quality GrowthAre margins and returns improving?
32
85
CashflowEarnings quality: real cash, not paper profit
4
64
Fin. StrengthBalance sheet, leverage, solvency risk
59
27
InvestmentDisciplined investing over empire-building
72
92
Low VolatilityCalm price path (market factor)
39
52
MomentumPrice trend over the last 3–12 months (market factor)
14
21
52W MomentumDistance to the 52-week high (market factor)
5
7
Net IssuanceShare count: buybacks or dilution?
0
83

What the models say

How far the median fair value (base case) per model family sits from the current price, in percent. The amount in the currency of the trading venue is shown underneath.

above the price, more than 15% above close to the price, 85% to 115% of the price below the price, more than 15% below

Model familyMEDIPOST Co.Price KRW 8,970Biotoxtech Co.Price KRW 2,240
DCF Modelsn/a+234%above the priceKRW 7,473
Earnings-Basedn/a-61%below the priceKRW 868
Multiplesn/a-30%below the priceKRW 1,558
Asset-Based-52%below the priceKRW 4,269-17%below the priceKRW 1,848
Growth DCFn/a+331%above the priceKRW 9,647
Economic Profitn/a-16%below the priceKRW 1,884
Growth Earningsn/a-34%below the priceKRW 1,481
Minimum-52%below the priceKRW 4,269-61%below the priceKRW 868
Maximum-52%below the priceKRW 4,269+331%above the priceKRW 9,647
Median-52%below the priceKRW 4,269-17%below the priceKRW 1,848
Geometric mean-52%below the priceKRW 4,269+9%close to the priceKRW 2,432

Minimum, maximum, median and geometric mean refer to the family values in this table. Geometric because deviations are ratios: half the price and twice the price average to 100%, not 125%.

MEDIPOST Co.: 1 of 1 models see the stock below the current price.

Biotoxtech Co.: 8 of 18 models see the stock below the current price.

Scenario ranges

From our cautious bear scenario to the optimistic bull scenario. The white tick is the current price (value above it), the green tick the fair value (value below it): if the price sits left of the fair value, there is room to rise.

MEDIPOST Co.
Price KRW 8,970
Fair Value KRW 3,576
Bear KRW 2,669Bull KRW 5,337
Biotoxtech Co.
Price KRW 2,240
Fair Value KRW 1,916
Bear KRW 1,916Bull KRW 1,925

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

MEDIPOST Co. · Health Care

Quality score26 · bottom 25%
Fair value upside-60% · bottom 25%

Biotoxtech Co. · Health Care

Quality score61 · above median
Fair value upside-14% · above median

Bottom line

As of Sep 24, 2026, Fair Value Calculator sees Biotoxtech Co. as the less overvalued of the two: MEDIPOST Co. trades at KRW 8,970 versus a fair value of KRW 3,576 (-60%), while Biotoxtech Co. trades at KRW 2,240 versus KRW 1,916 (-14%).

Biotoxtech Co. has the higher quality score (61/100).

Open Biotoxtech Co. live analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 26 models. Values change with price and fundamentals; the date shown above applies.